Can't disagree.Regardless of the entry price for each of us, this should have been so much bigger.It may still be, but unfortunately not under CHZ.Personally, am disappointed as I don't want US shares.....
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%